Lantheus Holdings, Inc. (FRA:0L8)

Germany · Delayed Price · Currency is EUR

57.64

-0.84 (-1.44%)

At close: Jan 9, 2026

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
PYLARIFY Revenue	1.01B	1.06B	Log In	Log In	Log In	Upgrade
Other Radiopharmaceutical Oncology Revenue	-	384.00K	Log In	Log In	Log In	Upgrade
Total Radiopharmaceutical Oncology Revenue	1.01B	1.06B	Log In	Log In	Log In	Upgrade
DEFINITY Revenue	331.10M	317.79M	Log In	Log In	Log In	Upgrade
TechneLite Revenue	90.93M	95.49M	Log In	Log In	Log In	Upgrade
Other Precision Diagnostics Revenue	24.86M	24.23M	Log In	Log In	Log In	Upgrade
Total Precision Diagnostics Revenue	467.33M	437.51M	Log In	Log In	Log In	Upgrade
Strategic Partnerships and Other Revenue	43.74M	38.18M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.53B	1.53B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Product Revenue	1.51B	1.52B	Log In	Log In	Log In	Upgrade
License and Royalty Revenue	19.67M	9.13M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.53B	1.53B	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.